These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15691289)

  • 1. Multiple sclerosis: long-term remission after a high dose of cyclophosphamide.
    de Bittencourt PR; Gomes-da-Silva MM
    Acta Neurol Scand; 2005 Mar; 111(3):195-8. PubMed ID: 15691289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
    Gladstone DE; Zamkoff KW; Krupp L; Peyster R; Sibony P; Christodoulou C; Locher E; Coyle PK
    Arch Neurol; 2006 Oct; 63(10):1388-93. PubMed ID: 16908728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
    Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
    Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation.
    Kreisel W; Potthoff K; Bertz H; Schmitt-Graeff A; Ruf G; Rasenack J; Finke J
    Bone Marrow Transplant; 2003 Aug; 32(3):337-40. PubMed ID: 12858208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose cyclophosphamide treatment in Marburg variant multiple sclerosis A case report.
    Nozaki K; Abou-Fayssal N
    J Neurol Sci; 2010 Sep; 296(1-2):121-3. PubMed ID: 20579663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis.
    Jeffery DR
    J Neurol Sci; 2004 Aug; 223(1):41-6. PubMed ID: 15261559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term experience with induction treatment regimens in multiple sclerosis.
    Le Page E; Edan G
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S46-9. PubMed ID: 19200867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
    Cendrowski W
    Acta Neurol Belg; 1973; 73(4):209-19. PubMed ID: 4770124
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports.
    Novik AA; Ionova TI; Bisaga GN; Kishtovich AV; Fedorenko DA; Ivanov RA; Gorodokin GI
    Cytotherapy; 2005; 7(4):363-7. PubMed ID: 16162458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.
    Roccatagliata L; Rocca M; Valsasina P; Bonzano L; Sormani M; Saccardi R; Mancardi G; Filippi M;
    Mult Scler; 2007 Sep; 13(8):1068-70. PubMed ID: 17468445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pediatric idiopathic pulmonary hemosiderosis with low-dose cyclophosphamide.
    Huang SH; Lee PY; Niu CK
    Ann Pharmacother; 2003 Nov; 37(11):1618-21. PubMed ID: 14565801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive central nervous system demyelination in an adolescent.
    Solanky M; Van Engel D; Wolansky L; Cook SD
    Rev Neurol Dis; 2005; 2(1):35-8. PubMed ID: 16400303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natalizumab treatment in pediatric multiple sclerosis: a case report.
    Borriello G; Prosperini L; Luchetti A; Pozzilli C
    Eur J Paediatr Neurol; 2009 Jan; 13(1):67-71. PubMed ID: 18406645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide therapy for MS.
    Gauthier SA; Weiner HL
    Int MS J; 2005 Aug; 12(2):52-8. PubMed ID: 16417815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures.
    Dussán KB; Magder L; Brodsky RA; Jones RJ; Petri M
    Lupus; 2008 Dec; 17(12):1079-85. PubMed ID: 19029275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
    Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
    Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year].
    Ory S; Debouverie M; Le Page E; Pelletier J; Malikova I; Gout O; Roullet E; Vermersch P; Edan G
    Rev Neurol (Paris); 2008 Dec; 164(12):1028-34. PubMed ID: 18808781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
    Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
    Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.